Cancer Clinical Trials in Amsterdam, North Holland
40 recruitingAmsterdam, North Holland, Netherlands
Showing 1–20 of 40 trials
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb990 enrolled237 locationsNCT07221357
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled274 locationsNCT06925737
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC1,310 enrolled281 locationsNCT06136624
Recruiting
Phase 2Phase 3
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Bristol-Myers Squibb470 enrolled157 locationsNCT07106762
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Extensive-stage Small-cell Lung Cancer
Bristol-Myers Squibb530 enrolled184 locationsNCT06646276
Recruiting
Phase 2Phase 3
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-small Cell Lung Cancer
Bristol-Myers Squibb596 enrolled185 locationsNCT07100080
Recruiting
Phase 2
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Metastatic CancerAdvanced CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc.200 enrolled120 locationsNCT05853575
Recruiting
Phase 2Phase 3
Contrast-enhanced Ultrasound for Sentinel Node Detection
Breast CancerMelanomaHead & Neck Cancer
The Netherlands Cancer Institute91 enrolled1 locationNCT07310758
Recruiting
Phase 2
Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction
Esophageal CancerAdenocarcinoma of the Esophagus
Erasmus Medical Center216 enrolled10 locationsNCT06161818
Recruiting
Phase 2
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Penile CancerUrogenital NeoplasmsPenile Squamous Cell Carcinoma+3 more
The Netherlands Cancer Institute27 enrolled2 locationsNCT06353906
Recruiting
Not Applicable
Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer
Prostate Cancer
St. Antonius Hospital503 enrolled7 locationsNCT07180381
Recruiting
Not Applicable
Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
Breast Cancer
The Netherlands Cancer Institute100 enrolled1 locationNCT06273800
Recruiting
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Early-onset Colorectal Cancer
The Netherlands Cancer Institute300 enrolled1 locationNCT06568679
Recruiting
Phase 1Phase 2
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Colorectal, CancerLiver MetastasesLiver Metastasis Colon Cancer
M.R. Meijerink120 enrolled1 locationNCT06630624
Recruiting
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Renal Cell CarcinomaRenal CancerRenal Cell Cancer Metastatic
PROspective Renal Cancer Cohort Foundation2,000 enrolled27 locationsNCT05326620
Recruiting
Phase 2
Towards Cure Via Only Ultra-short ICB in CSCC
Cutaneous Squamous Cell CancerCutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma (CSCC)+1 more
The Netherlands Cancer Institute41 enrolled5 locationsNCT06823479
Recruiting
Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
CancerCardiovascular DiseasesStroke+4 more
Hanneke W. M. van Laarhoven214 enrolled1 locationNCT06519292
Recruiting
Not Applicable
The Dragon PLC Trial (DRAGON-PLC)
CholangiocarcinomaHepatocellular Carcinoma (HCC)Primary Liver Cancer
Maastricht University358 enrolled55 locationsNCT06914648